Evidence map›Paper›PMID 36419252›Full record

ArticleCNS neuroscience & therapeutics2023

Inhibition of the JAK2/STAT3 pathway and cell cycle re-entry contribute to the protective effect of remote ischemic pre-conditioning of rat hindlimbs on cerebral ischemia/reperfusion injury.

Yongmei Zhao, Mao Ding, Feng Yan, Jie Yin, Wenjuan Shi, Nan Yang, Haiping Zhao, Yalan Fang, Yuyou Huang, Yangmin Zheng and 4 more

Open access · goldAbstract read
In one paragraph

Article in CNS neuroscience & therapeutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. The Journal of international medical research · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Yongmei ZhaoInstitute of Cerebrovascular Disease Research, Xuanwu Hospital of Capital Medical University, Beijing, China.ORCID 0000-0003-2337-3216
Mao DingInstitute of Cerebrovascular Disease Research, Xuanwu Hospital of Capital Medical University, Beijing, China.
Feng YanInstitute of Cerebrovascular Disease Research, Xuanwu Hospital of Capital Medical University, Beijing, China.
Jie YinInstitute of Cerebrovascular Disease Research, Xuanwu Hospital of Capital Medical University, Beijing, China.
Wenjuan ShiInstitute of Cerebrovascular Disease Research, Xuanwu Hospital of Capital Medical University, Beijing, China.
Nan YangInstitute of Cerebrovascular Disease Research, Xuanwu Hospital of Capital Medical University, Beijing, China.
Haiping ZhaoInstitute of Cerebrovascular Disease Research, Xuanwu Hospital of Capital Medical University, Beijing, China.
Yalan FangInstitute of Cerebrovascular Disease Research, Xuanwu Hospital of Capital Medical University, Beijing, China.
Yuyou HuangInstitute of Cerebrovascular Disease Research, Xuanwu Hospital of Capital Medical University, Beijing, China.
Yangmin ZhengInstitute of Cerebrovascular Disease Research, Xuanwu Hospital of Capital Medical University, Beijing, China.
Xueqi YangInstitute of Cerebrovascular Disease Research, Xuanwu Hospital of Capital Medical University, Beijing, China.
Wei LiInstitute of Cerebrovascular Disease Research, Xuanwu Hospital of Capital Medical University, Beijing, China.
Xunming JiInstitute of Cerebrovascular Disease Research, Xuanwu Hospital of Capital Medical University, Beijing, China.ORCID 0000-0003-0293-2744
Yumin LuoInstitute of Cerebrovascular Disease Research, Xuanwu Hospital of Capital Medical University, Beijing, China.ORCID 0000-0002-2712-8974
Capital Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsRemote ischemic pre-conditioning (RIPC) protects against ischemia/reperfusion (I/R) injury. However, the mechanisms underlying this protection remain unclear. In the present study, we investigated the role of Janus-activated kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) pathway and cell cycle arrest, and their relationship with neuronal apoptosis following RIPC.

methodsA rat cerebral I/R injury model was induced by middle cerebral artery occlusion (MCAO), and AG490 was used to investigate the mechanisms of RIPC. p-JAK2-, p-STAT3-, cyclin D1-, and cyclin-dependent kinase 6 (CDK6) expression was assessed by Western blotting and immunofluorescence staining.

resultsRIPC reduced the infarct volume, improved neurological function, and increased neuronal survival. Furthermore, p-JAK2 and p-STAT3 were detected during the initial phase of reperfusion; the expression levels were significantly increased at 3 and 24 h after reperfusion and were suppressed by RIPC. Additionally, the MCAO-induced upregulation of the cell cycle regulators cyclin D1 and CDK6 was ameliorated by RIPC. Meanwhile, cyclin D1 and CDK6 were colocalized with p-STAT3 in the ischemic brain.

conclusionRIPC ameliorates the induction of the JAK2/STAT3 pathway and cell cycle regulators cyclin D1 and CDK6 by MCAO, and this net inhibition of cell cycle re-entry by RIPC is associated with downregulation of STAT3 phosphorylation.

Indexed as

Brain IschemiaIschemic PreconditioningReperfusion InjuryAnimalsCell CycleCyclin D1HindlimbInfarction, Middle Cerebral ArteryJanus Kinase 2RatsSignal TransductionSTAT3 Transcription FactorCyclin D1Jak2 protein, ratJanus Kinase 2STAT3 Transcription Factorcerebral ischemia/reperfusioncyclin D1cyclin-dependent kinases 6Janus-activated kinase 2/signal transducer and activator of transcription 3remote ischemic pre-conditioning

Identifiers

PMID36419252
PMCPMC9928551
OpenAlexW4309915816

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.